Clinical Trial Update: A Phase 3 Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of ustekinumab in Korean and Taiwanese patients with moderate-to-severe plaque-type psoriasis; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2012-10-05